Viewing Study NCT01852266


Ignite Creation Date: 2025-12-24 @ 4:30 PM
Ignite Modification Date: 2026-03-27 @ 5:46 PM
Study NCT ID: NCT01852266
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2013-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-10
Start Date Type: None
Primary Completion Date: 2015-07
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2013-05-08
First Submit QC Date: None
Study First Post Date: 2013-05-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-13
Last Update Post Date: 2016-09-15
Last Update Post Date Type: ESTIMATED